Cargando…
PI3Kα targeting, nipping pancreatic cancer evolution in the bud
Thibault et al (2021) elucidate key signalling events mediating metastatic evolution in pancreatic ductal adenocarcinoma (PDAC) by demonstrating a role of PI3Kα in the regulation of macro‐metastatic disease and a corresponding pro‐tumoural immune response supporting disease progression.
Autores principales: | Raja Arul, Glancis Luzeena, Fernandez‐Zapico, Martin E |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8261515/ https://www.ncbi.nlm.nih.gov/pubmed/34057823 http://dx.doi.org/10.15252/emmm.202114362 |
Ejemplares similares
-
Drug-induced resistance: nipping it in the ‘budding’
por: Goldman, Aaron
Publicado: (2018) -
Toward personalized TGFβ inhibition for pancreatic cancer
por: Carr, Ryan M, et al.
Publicado: (2019) -
Patient‐derived organoids, creating a new window of opportunities for pancreatic cancer patients
por: Sandhya, Sandhya, et al.
Publicado: (2022) -
The bud awakens: Interplay among hormones and sugar controls bud release
por: Moreno, Sebastian R
Publicado: (2023) -
Nipping Adipocyte Inflammation in the Bud
por: Griffin, Michael J.
Publicado: (2021)